Objective-We hypothesized that ob/ob mice develop expansive vascular remodeling associated with calcification. Approach and Results-We quantified and investigated mechanisms of vascular remodeling and vascular calcification in ob/ob mice after vitamin D 3 (VD) stimulation or PBS (control), compared with C57BL/6 mice. Both ob/ob (OBVD [VD-treated ob/ob mice]) and C57BL/6 (C57VD [VD-treated C57BL/6 mice]) received 8×10 3 IU/day of intraperitoneal VD for 14 days. Control ob/ob (OBCT [PBS-treated ob/ob mice]) and C57BL/6 (C57CT [PBS-treated C57BL/6 mice]) received intraperitoneal PBS for 14 days. Hypervitaminosis D increased the external and internal elastic length in aortae from OBVD, resulting in increased total vascular area and lumen vascular area, respectively, which characterizes expansive vascular remodeling. OBVD decreased the aortic wall thickness, resulting in hypotrophic vascular remodeling. We demonstrated increased collagen deposition, elastolysis, and calcification in aortae from OBVD. Our results showed a positive correlation between expansive vascular remodeling and vascular calcification in OBVD. We demonstrated increased serum calcium levels, augmented Bmp (bone morphogenetic protein)-2 and osteochondrogenic proteins expression in OBVD aortae. Furthermore, aortae from OBVD increased oxidative stress, coincidently with augmented in situ MMP (matrix metalloproteinase) activity and exhibited no VDR (VD receptor) inhibition after VD. Conclusions-Our data provide evidence that obese and insulin-resistant mice (ob/ob) developed expansive hypotrophic vascular remodeling correlated directly with increased vascular calcification after chronic VD stimulation. Positive hypotrophic vascular remodeling and vascular calcification in this mouse model is possibly mediated by the convergence of absence VDR downregulation after VD stimulation, increased reactive oxygen species generation, and MMP activation. Visual Overview-An online visual overview is available for this article.
V ascular remodeling is a vessel response to mechanical and hemodynamic stimuli, 1 which is a major determinant of changes in vessel lumen caliber. 2 Vascular remodeling has been defined as any change in the whole-vessel area circumscribed by the external elastic lamina 3 that may occur either as a physiological hemodynamic response or as the hallmark of several cardiovascular diseases, 4 such as vascular aneurysm and dissection, 5 atherosclerosis and arteriosclerosis, 6 and systemic arterial hypertension. 7, 8 See accompanying editorial on page 117
The mechanisms that influence arterial remodeling include calcification, fibrosis, hyperplasia, and dedifferentiation of vascular smooth muscle cells (VSMC), changes in collagen and elastin content in the vessel wall, and endothelial dysfunction. 5 Vascular calcification (VC) increases cardiovascular morbidity and mortality, 9 especially in patients with type 2 diabetes mellitus (T2DM) 10 and chronic kidney disease. 11 For decades, VC has been described as a degenerative disease or as a consequence of aging. 12 However, recent studies have shown that VC is a complex, regulated process 13, 14 similar to osteochondrogenesis. 15 Diabetes mellitus is a major risk factor for cardiovascular disease. 10, 16 Although epidemiological and experimental studies demonstrated that VC is increased in diabetes mellitus, 17 the interrelated effect between VC and vascular remodeling in T2DM is unknown. Our laboratory and others have shown the importance of reactive oxygen species (ROS) generation, specifically H 2 O 2 , in the progression of VC 18 and aortic valve stenosis. 19 Increased ROS may trigger MMP (matrix metalloproteinase) activity 16, 20 and changes in collagen and elastin deposition/resorption. 21 MMPs are members of a family of Zn
2+
-and Ca
-dependent endopeptidases secreted by many types of cells. In fact, vascular cells can secrete MMPs, which plays a crucial role in vascular remodeling, by degrading extracellular matrix (ECM) components. 21, 22 However, the mechanisms involved in the augmented ROS production, VSMC differentiation, VC progression, and MMP activation that result in vascular remodeling are not understood in T2DM. Here, we investigated the effect of cholecalciferol (vitamin D 3 ) on vascular remodeling and calcification in a murine model of obesity and insulin resistance (ob/ob mice), compared with C57BL/6 mice. Moreover, we addressed mechanisms by which calcification may influence vascular remodeling in ob/ ob mice, such as increased ROS production, cell death, MMP activity, VSMC dedifferentiation, and VDR (vitamin D receptor) expression.
Materials and Methods
The authors declare that all supporting data are available within the article and its online-only Data Supplement.
Animals
All animal studies were in accordance with the guidelines for the use of animals in research and were approved by both the University of São Paulo Medical School and the Albert Einstein Hospital Ethical Committee (protocol no. 129/15 and no. 1764-13, respectively). We used 16-to 20-week-old male homozygous leptin-deficient ob/ ob mice, also known as B6-ob, from the Jackson Laboratory (Bar Harbor, ME) and background control C57BL/6 littermates. Mice were fed a standard chow diet and were provided sterilized water ad libitum. 
Mouse Model of VC

Blood and Serum Analysis
Serum calcium was analyzed by an Abbott i-STAT analyser using Chem 8+ Cartridges (catalog no. AB-9P3125; Abbott Laboratories, IL). Serum phosphorus was assessed using FOSFORO UV Liquiform (catalog no. 10009010051, Labtest, Brazil).
Quantitative and Semiquantitative Image Analysis
For histomorphological and quantitative analysis, we used CellSens Dimension Software (Olympus Corporation, Tokyo, Japan). Fluorescence imaging was performed by a Zeiss LSM 710 laser scanning confocal microscope (Carl Zeiss AG, Oberkochen, Germany) and analyzed by Zeiss Zen Software.
Quantification of Vascular Remodeling
After euthanasia, the thoracic aorta was perfused with PBS and fixed using continuous pressure in 10% formalin. The ascending aorta was catheterized, and PBS was infused under continuous pressure (100 mm Hg) for 1 hour. The thoracic aorta was collected and embedded in paraffin. Vascular remodeling analysis was performed in tissue sections by planimetry. We measured vascular wall thickness, total vascular area, lumen area, internal elastic lamella, and external elastic lamella linear length. Another section of aorta was freshly frozen in Tissue-Tek O.C.T Compound (VWR catalog no. 25608-930; Sakura Finetek, CA) for immunofluorescence, in situ oxidant generation and metalloproteinase activity analyses.
ECM Analysis
We performed hematoxylin and eosin (catalog no. H3136 and E4009; Sigma), Verhoeff-Van Gieson (catalog no. HT25A; Sigma), Masson trichrome (Sigma catalog no. HT15), and Alizarin Red S (catalog no. A5533; Sigma) staining.
Tissue Calcification Assessment
We measured the calcification area and the percent ratio of the calcification area in relation to the total vascular area calculated as the mean of 6 tissue sections stained with Alizarin Red S staining.
Ex Vivo Aortic Calcification by Osteosense
Aortic calcification was also assessed by tissue spectrofluorimeter using Osteosense 680EX (catalog no. NEV10020EX; Perkin Elmer), which binds to calcium and fluoresces at 675/720 nm (ex/em) 23 Osteosense solution at 0.2 μM was administered intraperitoneally at the end of protocol using a volume of 100 μL/animal. After 24 hours, euthanasia was performed, as described, and the aorta was perfused with saline and dissected for analysis on a black surface to abrogate fluorescence reflectance. Quantification was performed using an IVIS Lumina LT Series III spectrofluorimeter (PerkinElmer) with an exposure time of 4 ms and a field of view of 12.5 cm.
Quantification of Elastolysis
After Verhoeff-Van Giesson staining, elastolysis was analyzed by counting the loss of integrity of elastic fiber segments of the thoracic aorta.
Measurement of Fibrosis
After Masson trichrome staining, we assessed the area of fibrosis and the percentage of fibrosis in relation to the total vascular area. 
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Immunofluorescence
Briefly, optimal cutting temperature-embedded thoracic aorta was cut into 6-μm thick sections in silane-prep slides for immunofluorescence. Then, aorta samples were washed and incubated with a primary antibody overnight, followed by washing to remove excess of primary antibody, and followed by subsequent incubation with the appropriate host secondary antibody for 1 hour. Negative (FBS without primary Ab) controls were used in all experiments and stained simultaneously. We used Hoechst (catalog no. H1399; Thermo Fisher Scientific) for nuclei staining to estimate the number of cells/field.
In Situ Zymography
Gelatinolytic activity was analyzed in 6-μm thick optimal cutting temperature-embedded tissue sections using DQ gelatin as a substrate (catalog no. E12055; EnzChek Gelatinase/Collagenase Assay Kit; Thermo Fisher Scientific). DQ gelatin was dissolved in water to a concentration of 1 mg/mL. This stock was diluted 1:10 in reaction buffer according to the manufacturer's protocol. The mixture (50 μL) was added to cover tissue sections, which were incubated for 6 hours at room temperature. Proteolytic activity was detected in green fluorescence (530 nm) by Zeiss confocal microscope. The negative control was incubated in the presence of the MMP inhibitor provided with abovementioned kit.
Quantification of Oxidant Generation In Vivo
All groups received 5,5-dimethyl-1-pyrroline N-oxide (catalog no. ALX-430-090-G001; Enzo Life Sciences) dissolved in pyrogen-free saline (2.0 g/kg total) intraperitoneally in 2 doses (6 and 2 hours) before euthanasia, according to the method described by Khoo et al. 24 After euthanasia, the thoracic aorta was perfused with PBS, removed, and fixed in Tissue-Tek O.C.T. Compound and stored at −80°C for analysis. Then, frozen 6-μm thick sections were incubated with anti-5,5-dimethyl-1-pyrroline N-oxide antibody (catalog no. ab110429; Abcam) 9.6 µg/mL overnight.
TUNEL Assay for Quantifying Cell Death
Cell death quantification per field was performed with terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) Assay Kit (catalog no. ab66110; Abcam) as described by the company's protocol. TUNEL-positive cells were imaged by Zeiss confocal microscope using 576 nm emission and quantified by Zen software.
Statistical Analysis
Results are shown as the means±SEM. After assessing normality and equal variance, data were analyzed by 1-way ANOVA followed by Student-Newman-Keuls multiple comparisons posttest or KruskalWallis test (nonparametric ANOVA) followed by Dunn multiple comparisons posttest, as appropriated. Significance was set at P<0.05. Pearson correlation test was used to measure the strength of association between 2 variables. Data were analyzed using Prism GraphPad 5.0 software (GraphPad Software, Inc, La Jolla, CA).
Results
Hypotrophic and Expansive Vascular Remodeling in ob/ob Mice Aorta Stimulated by Vitamin D 3 In Vivo
Aortae from OBVD showed statistically significant increase in the cross-sectional diameter at the macroscopic level when compared with those from the other groups. OBVD aorta manipulation and dissection demonstrated a gelatinous consistency with reduced elasticity ( Figure 1A ), revealing a fragile tissue. Hypervitaminosis D significantly increased the external elastic length in aortae from OBVD compared with those from the other 3 groups ( Figure 1B and 1C), resulting in significantly increased total vascular area ( Figure 1D ), which characterizes expansive vascular remodeling. Furthermore, we showed a significantly increased internal elastic length in aortae from OBVD compared with those from the other groups ( Figure 1E ), depicting statistically significant augmented vascular lumen area (Figures 1F and 1B) and positive vascular remodeling. In addition, OBVD significantly decreased the aortic wall thickness, resulting in concomitant hypotrophic vascular remodeling ( Figure 1G ). We used only male mice to avoid the influence of the hormonal differences between male and female in results. Nevertheless, we tested the calcifying protocol in a small number of female ob/ob (n=6) and C57BL/6 mice (n=6), and we found positive hypotrophic vascular remodeling, as demonstrated by augmented external elastic lamellae linear length and decreased vascular wall thickness in female OBVD ( Figure I in the online-only Data Supplement). 
Increased OBVD VC
Alizarin Red S staining depicted augmented vascular mineralization in OBVD aortae characterized by calcium deposition contiguous with elastic lamellae after 14 days of treatment, compared with no or minimum calcification in paired C57BL/6 and C57VD (Figure 2A ). The calcification area and the percentage of calcification in relation to the total vascular area are shown in Figure 2B and Figure 2C , respectively. OBVD demonstrated an increased fluorescence signal (yellow) of aorta compared with paired C57BL/6 mice (red) using Osteosense, denoting greater VC after calcifying stimulus ( Figure 2D ). In summary, ob/ob mice had accelerated progression of VC associated with increased expansive and hypotrophic positive vascular remodeling after in vivo administration of vitamin D ( Figure 2E ). Together, these results showed a positive correlation between expansive vascular remodeling and VC in OBVD, as seen in Figure 2E .
Increased Serum Calcium Levels in ob/ob and in C57BL/6 Mice After Calcifying Stimulus
The exaggerated VC response of OBVD was accompanied by a statistically significant increase in serum calcium versus OBCT ( Figure 3A) . We found no change in serum phosphorus concentration ( Figure 3B ) both in OBVD and in C57VD 
Expression of Osteochondrogenic Markers in the Vascular Wall
We showed increased osteochondrogenic program activation in aortae from OBVD, but not from C57VD, as demonstrated by augmented Bmp (bone morphogenetic protein)-2, Msx2 (Msh homeobox 2), Runx2 (runt-related transcription factor 2), and Alpl (alkaline phosphatase) expression (Figure 4 ) after VD stimulation.
Absence of VDR Downregulation in Aortae From ob/ob Mice Challenged With VD
To further investigate increased osteochondrogenic and calcification response in aortae from insulin resistance mice after VD stimulation, we addressed VDR expression. We demonstrated decreased VDR expression after vitamin D 3 stimulation in C57VD versus C57CT, but we found no inhibition of VDR expression in OBVD aortae in comparison to OBCT. VDR expression increased in OBVD versus C57VD. Aortae from OBCT showed decreased VDR expression levels versus C57CT animals ( Figure 5 ). Compartmentalization of VDR expression showed VDR signal mainly localized in nuclei (all groups).
Enhanced ECM Fibrosis and Elastolysis of the Vascular Wall in OBVD
We demonstrated statistically significant increase in collagen deposition in the aortae from OBVD compared with OBCT ( Figures 6A-6C ). As shown in Figure 6A , collagen deposition mainly occurred around calcifying foci in OBVD aortae, and there was a positive correlation between fibrosis and VC in these mice (R 2 =0.8, P<0.05). We did not observe fibrosis in C57CT or C57VD ( Figure 6A ). Furthermore, we demonstrated changes in the architecture of the elastic fibers (elastolysis or rupture of the elastic fibers), especially around calcifying foci in aortae from OBVD, compared with OBCT and C57CT (Figure 6D-6E) . We did not observe fragmentation of elastic fibers in C57VD and in C57CT ( Figure 6B ).
Metalloproteinase Activity In Situ
We found statistically significant enhancement of MMP activity in aortae from OBVD compared with those from paired OBCT, as demonstrated by increased fluorescence intensity. Paired negative internal control using the MMP inhibitor 1,10-phenanthroline attenuated fluorescence signal ( Figure 7A ).
ROS Generation
Compared with C57VD and paired control mice, aortae from OBVD showed significantly increased oxidative stress, as demonstrated by prominent augmented anti-5,5-dimethyl-1-pyrroline N-oxide fluorescence adjacent to calcifying foci ( Figure 7B and 7C ).
Cell Death
We showed increased TUNEL-positive cells in aortae from OBVD mainly around calcifying foci, compared with C57VD ( Figure II in the online-only Data Supplement).
Discussion
We investigated the impact of vitamin D 3 in vascular remodeling associated with VC in ob/ob mice. Here, we demonstrate, to the best of our knowledge, that obese and insulin-resistant mice (ob/ob) develop positive hypotrophic vascular remodeling accompanying augmented medial layer calcification after chronic cholecalciferol stimulation. Vessel remodeling was characterized by increased vessel diameter and decreased wall-to-lumen ratio (thinning of the vascular wall and increased vascular lumen area), thus characteristic of positive hypotrophic remodeling. 7 Moreover, positive hypotrophic vascular remodeling correlated directly with increased VC in OBVD but not in C57VD.
Our data showed that augmented ROS formation and Bmp-2 expression may underlie increased downstream osteogenic programming and calcification in OBVD aortae. 25, 26 Bmp-2 and Bmp-4 are upregulated in diabetes mellitus and in high-glucose conditions. 15 Moreover, both are inflammatory mediators in vascular endothelium responsive to disturbed flow, increased oxidative stress, and inflammation, 27, 28 promoting atherosclerosis and calcification. 29 In fact, MGP (matrix Gla protein) transgenic mice crossbred with ApoE null mice decreased Bmps activity, limiting atherosclerotic lesions formation and VC 29 . On the contrary, Bmp-7 plays a role in maintaining VSMC status and preventing VSMC dedifferentiation into an osteoblast phenotype. 30, 31 Previous report also showed that Bmp-2 and Bmp-7 inhibit VSMC proliferation induced by LDL (low-density lipoprotein) in vitro. 32 In this context, Bmps signaling may have influenced expansive hypotrophic remodeling, by regulating VSMC proliferation, dedifferentiation, and death, 33 in addition to VC, in our model. Several studies demonstrated that ROS and Bmp-2 expression play an important role in VC. 18, 19, [34] [35] [36] Although we showed increased ROS formation in the vascular wall from OBVD, we did not address its specific source, either from endothelial cells, VSMC, or the adventitia. However, we previously demonstrated that Bmp-2-treated VSMC from human coronary arteries promote NADPH oxidase activation and osteogenic dedifferentiation in a p22 phox -dependent manner. 36 Increased oxidative/nitrosative stress and decreased NO bioavailability are also known to contribute to aortic valve calcification 35 and occur around calcium deposits. 19 H 2 O 2 increases Runx2 expression, promoting VSMC dedifferentiation into an osteogenic phenotype. 37 Hyperglycemia may also potentiate VC via increased oxidative stress. 38 Our results confirm that obesity and insulin resistance accelerate VC in vivo, as we previously reported in vitro by demonstrating that VSMC from ob/ob mice are more sensitive to Bmp-2 induced osteochondrogenic differentiation and calcification. 26 Accordingly, it is possible that an epigenetic regulatory mechanism or a consequence of metabolic dysfunction may influence gene and protein expression. Another possible mechanism may involve vitamin D receptors, known to support the regulation of numerous transcription factors supporting ectopic calcification. 39 VDR blockade was previously shown to attenuate atherosclerotic calcification in VDR-deficient mice in an Apoe −/− background when challenged with a high-fat diet for 18 weeks, by decreasing osteochondrogenic program activation downstream of VDR-dependent transcription factors. 40 Also, monocytes from T2DM patients have lower VDR expression levels than nondiabetics. 41 Moreover, VDR expression increased in adipose tissue from obese but decreased in lean individuals after VD supplementation. 42 Interestingly, investigators showed decreased VDR expression in renal tubular epithelial cells in comparison to nondiabetic patients. 43 Furthermore, they found that TNF (tumor necrosis factor)-α downregulates VDR expression via miR (microRNA)-346 in peripheral blood mononuclear cells. Given these data, our demonstration that only C57BL/6 mice showed repressed aortic VDR expression after VD stimulation is relevant. Contrarily, the already lower VDR expression in ob/ob mice was insensitive to VD, unveiling a possible mechanism of increased osteochondrogenic VSMC dedifferentiation in insulin-resistant mice. Accordingly, there was augmented Bmp-2, Msx2, Runx2, and Alpl protein expression in aortae from OBVD compared with C57VD. Although passive calcium accrual in the vascular wall from mice given excess vitamin D 3 may occur, 44 our data reinforce active cell reprogramming as an underlying mechanism. Moreover, we reported increased TUNEL-positive cells in OBVD aortae. VSMC-and macrophage-derived matrix vesicles contribute to microcalcification during apoptosis. 45 Accordingly, hyperglycemia increases AGE (advanced glycation end-products) and RAGE (receptor for advanced glycation end products) signaling, which may induce apoptosis and calcification by increasing ROS and osteogenic program activation. 38 Vascular remodeling is the result of orchestrated mechanisms, including VSMC proliferation, differentiation, apoptosis, changes in ECM architecture, such as modification of collagen type and content, elastin degradation and rupture, besides calcification, and endothelial dysfunction. 6 Similar to the increased elastocalcinosis in aortae from OBVD, elastocalcinosis is also present in MGP-deficient mice. 46 MGP inhibits VC, requiring gamma-carboxylation to be functionally active. Higher desphospho-uncarboxylated MGP levels associate with high risk of cardiovascular disease in T2DM. 47 MGP activity is also decreased in patients using vitamin K inhibitors, such as warfarin. 48 Moreover, elastocalcinosis occurs in parallel with elastin degradation (Figure 6D and 6E) , an important niche for VC initiation, 5 progression, and accompanying vascular remodeling. 49, 50 Elastolysis may have contributed to positive vascular remodeling and gelatinous consistency of the vessel wall in our work. Modification of aortae's elastic properties decreases vascular recoil and compliance. 5 Furthermore, we demonstrated intense deposition of collagen, mainly around the calcifying foci in OBVD aortae. Sex differences and respective hormones impact cardiovascular disease and animal models. 51 Elastase-induced abdominal aortic aneurysm model promotes smaller aortic expansion in female than in male mice. 52 In fact, estradiol plays a crucial role in limiting aortic aneurysm expansion, 53 by inhibiting NF-κB (nuclear factor κB)-mediated proinflammatory gene induction in apoE-deficient mice, 54 besides decreasing aortic macrophage infiltration and MMP-9 production in rats. 55 Decreased estrogen production abolishes protection against aneurysm formation in females. 53 On the contrary, calcium chloride-mediated abdominal aortic aneurysm model did not demonstrate a difference in male and in female mice. In this context, the hypotrophic vascular remodeling observed in a set of female OBVD is an interesting result that merits further investigation.
Our interesting result showing positive association of vascular remodeling, and VC in OBVD suggests a mechanistic convergence between those 2 processes in insulinresistant mice. As such, the mechanisms discussed above for calcification may also apply for vascular remodeling. The possible role of VDR in vessel remodeling is suggested by reported correlations among VDR genotype vitamin D status and MMP, with TaqI VDR gene polymorphism influencing circulating TIMP-1 (tissue inhibitor of metalloproteinases 1) levels. 56 MMP activation, 49, 50 such as elastase and other proteases, has a pivotal role in vascular remodeling by degrading ECM components. 16, 21, 57 In parallel, redox processes are a crucial mechanism underlying vascular remodeling. Along this line, a mechanistic insight from our study was the redox-dependent MMP activation, smooth muscle cell apoptosis, and dedifferentiation of VSMC. 20, 59 Minol et al 60 showed that local induction of ROS-release in vivo is followed by increased MMP activity and calcification of the vessel wall from male Wistar rats that received vitamin D and phosphate-enriched diet. Oxidant levels were substantially increased in OBVD aortae and may likely have contributed to increased MMP activation. ROS generation and oxidative stress/antioxidant imbalance have been demonstrated both in diabetic patients 61 and in diabetic mice. 62 Diabetes mellitus itself may augment MMP activity in vascular cells. 16 In parallel, inflammatory cytokines can induce MMP activation during VC either directly 21, 22, 63 or via plasmin upregulation. 64 Overall, vascular remodeling and calcification are regulated by numerous mediators and complex signaling pathways. A limitation of our study is that we addressed part of these mechanisms.
One translational implication of our study relates to the increasing clinical use of VD supplementation, with healthcare providers not infrequently overtreating VD insufficiency. 65, 66 Additionally, motivation for skeletal and nonskeletal health benefits of VD supplementation parallels imprecise 25-hydroxyvitamin D plasma measurements, along with equivocal adequacy of vitamin D status and high loading dose protocols which may have potentially harmful effects. Of note, no large well-designed randomized control trials clarified if vitamin D supplementation to an optimal serum level may benefit immunity and inflammatory response, reduce the risk of cancer, decrease cardiovascular disease or the chance of developing diabetes mellitus, and improve glycemic control. 67 Although we can anticipate circulating VD increment according to oral VD dose in majority of population, this may be erratic in the context of diabetes mellitus and chronic kidney disease patients, which may present with altered parathyroid hormone, phosphaturic hormone FGF (fibroblast growth factor)-23, and unregulated 1α-hydroxylase. 68 This may result in increased active hormonal form 1,25-dihydroxyvitamin D, thus augmenting calcium-phosphorus product, which corroborates ectopic calcification. 69 Indiscriminate long-term supplementation of vitamin D may be harmful to specific group of patients, especially diabetic and chronic kidney disease patients, which may have an exaggerated ectopic and VC response to VD, as we demonstrated in our model.
Conclusions
We demonstrated that obesity and insulin resistance play an important role in VC response to cholecalciferol in vivo, resulting in increased ectopic mineralization signaled by specific osteochondrogenic program activation and associated positive, hypotrophic vascular remodeling. This finding may be relevant to explain accelerated vascular aging and disease in diabetes mellitus, which contributes to poor cardiovascular outcome, 70 by increasing pulse pressure, pulse wave velocity, and left ventricular diastolic dysfunction, 71 thus causing disturbed blood flow and end-organ perfusion imbalance and damage. 1, 72 Mechanistically, we consider that exaggerated remodeling and mineralization in aortae from ob/ob mice may result from the convergence of increased oxidative stress, absence of VDR suppression after cholecalciferol, which potentiate osteogenic genes activation, VC, increased cell death, and MMP activity, contributing to other described vascular architecture and conformational changes in aortae from mice with insulin resistance and obesity (Figure 8 ). These findings are important to further understand signaling pathways and to foster therapeutic developments that may attenuate the progression of VC associated with elastolysis and vascular remodeling, contributing to decrease cardiovascular mortality in obesity, insulin resistance, and diabetes mellitus. Augmented calcium-phosphorus product, apoptosis, and osteogenic program activation stimulate VC. VD binds to VDR (VD receptor), which activates VD responsive elements (VDRE) to increase osteogenic transcription factors and proteins expression, such as Msx2 (Msh homeobox 2), Runx2 (runt-related transcription factor 2), Bmp (bone morphogenetic protein)-2, and Alpl (alkaline phosphatase) that promote vascular smooth muscle cells (VSMC) dedifferentiation and VC. In lean C57BL/6 mice, this signaling cascade is abrogated by VDR suppression after VD stimulation, thus decreasing osteogenic program activation. Inhibition of VDR expression does not occur in obese, insulin-resistant mice. Accordingly, ob/ob mice showed increased active cellular reprogramming into osteochondrogenic phenotype, potentiating VC. In addition, increased reactive oxygen species (ROS) production by Bmp-2 and vice-versa in ob/ob mice promotes apoptosis and VC. Bmps regulate VSMC proliferation, dedifferentiation, and death, thus modulating vascular remodeling. Augmented MMP (matrix metalloproteinase) activity by ROS increases extracellular matrix degradation. VC contributes to elastocalcynosis, which causes elastin fibers rupture. Taken together, ob/ob mice increase VC, which favors vascular remodeling in our model. Continuous line and upward pointing arrow depicts stimulation; dashed line indicates inhibition.
